Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction.

Raz L, Bhaskar K, Weaver J, Marini S, Zhang Q, Thompson JF, Espinoza C, Iqbal S, Maphis NM, Weston L, Sillerud LO, Caprihan A, Pesko JC, Erhardt EB, Rosenberg GA.

Neurobiol Dis. 2018 Jul 12. pii: S0969-9961(18)30242-0. doi: 10.1016/j.nbd.2018.07.009. [Epub ahead of print] Review.

PMID:
30010004
2.

Editorial: WHO Guidelines on Community-Level Interventions to Manage Declines in Intrinsic Capacity: The Road for Preventing Cognitive Declines in Older Age?

Vellas B, Scrase D, Rosenberg GA, Andrieu S, Araujo de Carvalho I, Middleton LT.

J Prev Alzheimers Dis. 2018;5(3):165-167. doi: 10.14283/jpad.2018.26. No abstract available.

PMID:
29972207
3.

Biomarkers identify the Binswanger type of vascular cognitive impairment.

Barry Erhardt E, Pesko JC, Prestopnik J, Thompson J, Caprihan A, Rosenberg GA.

J Cereb Blood Flow Metab. 2018 Jan 1:271678X18762655. doi: 10.1177/0271678X18762655. [Epub ahead of print]

PMID:
29513153
4.

Vascular tight junction disruption and angiogenesis in spontaneously hypertensive rat with neuroinflammatory white matter injury.

Yang Y, Kimura-Ohba S, Thompson JF, Salayandia VM, Cossé M, Raz L, Jalal FY, Rosenberg GA.

Neurobiol Dis. 2018 Jun;114:95-110. doi: 10.1016/j.nbd.2018.02.012. Epub 2018 Feb 24.

PMID:
29486300
5.

Blood-ocular barrier leakage: Further evidence for remote effects following ischemic stroke.

Schlachetzki F, Rosenberg GA.

Neurology. 2018 Mar 13;90(11):491-492. doi: 10.1212/WNL.0000000000005131. Epub 2018 Feb 7. No abstract available.

PMID:
29438038
6.

MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies.

Raja R, Rosenberg GA, Caprihan A.

Neuropharmacology. 2018 May 15;134(Pt B):259-271. doi: 10.1016/j.neuropharm.2017.10.034. Epub 2017 Oct 28. Review.

PMID:
29107626
7.

Binswanger's disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia.

Rosenberg GA.

J Neurochem. 2018 Mar;144(5):634-643. doi: 10.1111/jnc.14218. Epub 2017 Nov 6. Review.

PMID:
28902409
8.

Extracellular matrix inflammation in vascular cognitive impairment and dementia.

Rosenberg GA.

Clin Sci (Lond). 2017 Mar 1;131(6):425-437. doi: 10.1042/CS20160604. Review.

PMID:
28265034
9.

Translational models for vascular cognitive impairment: a review including larger species.

Hainsworth AH, Allan SM, Boltze J, Cunningham C, Farris C, Head E, Ihara M, Isaacs JD, Kalaria RN, Lesnik Oberstein SA, Moss MB, Nitzsche B, Rosenberg GA, Rutten JW, Salkovic-Petrisic M, Troen AM.

BMC Med. 2017 Jan 25;15(1):16. doi: 10.1186/s12916-017-0793-9. Review.

10.

Neuroimaging in vascular cognitive impairment: a state-of-the-art review.

Heiss WD, Rosenberg GA, Thiel A, Berlot R, de Reuck J.

BMC Med. 2016 Nov 3;14(1):174. Review.

11.

Rodent Models of Vascular Cognitive Impairment.

Yang Y, Kimura-Ohba S, Thompson J, Rosenberg GA.

Transl Stroke Res. 2016 Oct;7(5):407-14. doi: 10.1007/s12975-016-0486-2. Epub 2016 Aug 8. Review.

12.

Impaired renal function is associated with brain atrophy and poststroke cognitive decline.

Auriel E, Kliper E, Shenhar-Tsarfaty S, Molad J, Berliner S, Shapira I, Ben-Bashat D, Shopin L, Tene O, Rosenberg GA, Bornstein NM, Ben Assayag E.

Neurology. 2016 May 24;86(21):1996-2005. doi: 10.1212/WNL.0000000000002699. Epub 2016 Apr 27.

PMID:
27164678
13.

Analysis of pharmacokinetics of Gd-DTPA for dynamic contrast-enhanced magnetic resonance imaging.

Taheri S, Shah NJ, Rosenberg GA.

Magn Reson Imaging. 2016 Sep;34(7):1034-40. doi: 10.1016/j.mri.2016.04.014. Epub 2016 Apr 22.

14.

Matrix Metalloproteinase-Mediated Neuroinflammation in Vascular Cognitive Impairment of the Binswanger Type.

Rosenberg GA.

Cell Mol Neurobiol. 2016 Mar;36(2):195-202. doi: 10.1007/s10571-015-0277-4. Epub 2016 Mar 18. Review.

15.

Transient increase of fractional anisotropy in reversible vasogenic edema.

Kimura-Ohba S, Yang Y, Thompson J, Kimura T, Salayandia VM, Cosse M, Yang Y, Sillerud LO, Rosenberg GA.

J Cereb Blood Flow Metab. 2016 Oct;36(10):1731-1743. Epub 2016 Feb 10.

16.

Vascular cognitive impairment: Biomarkers in diagnosis and molecular targets in therapy.

Rosenberg GA.

J Cereb Blood Flow Metab. 2016 Jan;36(1):4-5. doi: 10.1177/0271678X15609542. No abstract available.

17.

Long-Term Blood-Brain Barrier Permeability Changes in Binswanger Disease.

Huisa BN, Caprihan A, Thompson J, Prestopnik J, Qualls CR, Rosenberg GA.

Stroke. 2015 Sep;46(9):2413-8. doi: 10.1161/STROKEAHA.115.009589. Epub 2015 Jul 23.

18.

Consensus statement for diagnosis of subcortical small vessel disease.

Rosenberg GA, Wallin A, Wardlaw JM, Markus HS, Montaner J, Wolfson L, Iadecola C, Zlokovic BV, Joutel A, Dichgans M, Duering M, Schmidt R, Korczyn AD, Grinberg LT, Chui HC, Hachinski V.

J Cereb Blood Flow Metab. 2016 Jan;36(1):6-25. Review.

19.

Matrix metalloproteinases as therapeutic targets for stroke.

Yang Y, Rosenberg GA.

Brain Res. 2015 Oct 14;1623:30-8. doi: 10.1016/j.brainres.2015.04.024. Epub 2015 Apr 25. Review.

20.

Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP.

Jalal FY, Yang Y, Thompson JF, Roitbak T, Rosenberg GA.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1145-53. doi: 10.1038/jcbfm.2015.21. Epub 2015 Feb 25.

21.

Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials.

Rosenberg GA, Prestopnik J, Adair JC, Huisa BN, Knoefel J, Caprihan A, Gasparovic C, Thompson J, Erhardt EB, Schrader R.

J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1324-30. doi: 10.1136/jnnp-2014-309421. Epub 2015 Jan 24.

22.

Binswanger's disease: toward a diagnosis agreement and therapeutic approach.

Huisa BN, Rosenberg GA.

Expert Rev Neurother. 2014 Oct;14(10):1203-13. doi: 10.1586/14737175.2014.956726. Epub 2014 Sep 9. Review.

23.

Identification of isoxsuprine hydrochloride as a neuroprotectant in ischemic stroke through cell-based high-throughput screening.

Hill JW, Thompson JF, Carter MB, Edwards BS, Sklar LA, Rosenberg GA.

PLoS One. 2014 May 7;9(5):e96761. doi: 10.1371/journal.pone.0096761. eCollection 2014.

24.

Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment.

Rosenberg GA, Bjerke M, Wallin A.

Stroke. 2014 May;45(5):1531-8. doi: 10.1161/STROKEAHA.113.004534. Epub 2014 Apr 1. Review. No abstract available.

25.

Blood-Brain Barrier Permeability in Aging and Alzheimer's Disease.

Rosenberg GA.

J Prev Alzheimers Dis. 2014 Mar;1(3):138-139. No abstract available.

26.

Tissue oxygen is reduced in white matter of spontaneously hypertensive-stroke prone rats: a longitudinal study with electron paramagnetic resonance.

Weaver J, Jalal FY, Yang Y, Thompson J, Rosenberg GA, Liu KJ.

J Cereb Blood Flow Metab. 2014 May;34(5):890-6. doi: 10.1038/jcbfm.2014.35. Epub 2014 Feb 19.

27.

Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations.

Hart BL, Taheri S, Rosenberg GA, Morrison LA.

Transl Stroke Res. 2013 Oct;4(5):500-6. doi: 10.1007/s12975-013-0285-y. Epub 2013 Sep 21.

28.

Neuroprotective role of a brain-enriched tyrosine phosphatase, STEP, in focal cerebral ischemia.

Deb I, Manhas N, Poddar R, Rajagopal S, Allan AM, Lombroso PJ, Rosenberg GA, Candelario-Jalil E, Paul S.

J Neurosci. 2013 Nov 6;33(45):17814-26. doi: 10.1523/JNEUROSCI.2346-12.2013.

29.

Early inhibition of MMP activity in ischemic rat brain promotes expression of tight junction proteins and angiogenesis during recovery.

Yang Y, Thompson JF, Taheri S, Salayandia VM, McAvoy TA, Hill JW, Yang Y, Estrada EY, Rosenberg GA.

J Cereb Blood Flow Metab. 2013 Jul;33(7):1104-14. doi: 10.1038/jcbfm.2013.56. Epub 2013 Apr 10.

30.

Quantification of blood-to-brain transfer rate in multiple sclerosis.

Taheri S, Rosenberg GA, Ford C.

Mult Scler Relat Disord. 2013 Apr;2(2):124-32. doi: 10.1016/j.msard.2012.09.003. Epub 2012 Oct 24.

31.
32.

1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment.

Gasparovic C, Prestopnik J, Thompson J, Taheri S, Huisa B, Schrader R, Adair JC, Rosenberg GA.

J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):715-21. doi: 10.1136/jnnp-2012-303878. Epub 2013 Feb 16.

33.

Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia.

Jin X, Liu J, Liu KJ, Rosenberg GA, Yang Y, Liu W.

Exp Neurol. 2013 Feb;240:9-16. doi: 10.1016/j.expneurol.2012.11.018. Epub 2012 Nov 26.

34.

Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons.

Hill JW, Poddar R, Thompson JF, Rosenberg GA, Yang Y.

Neuroscience. 2012 Sep 18;220:277-90. doi: 10.1016/j.neuroscience.2012.06.019. Epub 2012 Jun 16.

35.

Myelin loss associated with neuroinflammation in hypertensive rats.

Jalal FY, Yang Y, Thompson J, Lopez AC, Rosenberg GA.

Stroke. 2012 Apr;43(4):1115-22. doi: 10.1161/STROKEAHA.111.643080. Epub 2012 Feb 23.

36.

Neurological diseases in relation to the blood-brain barrier.

Rosenberg GA.

J Cereb Blood Flow Metab. 2012 Jul;32(7):1139-51. doi: 10.1038/jcbfm.2011.197. Epub 2012 Jan 18. Review.

37.

Imaging of subacute blood-brain barrier disruption after methadone overdose.

Huisa BN, Gasparovic C, Taheri S, Prestopnik JL, Rosenberg GA.

J Neuroimaging. 2013 Jul;23(3):441-4. doi: 10.1111/j.1552-6569.2011.00669.x. Epub 2011 Dec 30.

38.

Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

Yang Y, Rosenberg GA.

Stroke. 2011 Nov;42(11):3323-8. doi: 10.1161/STROKEAHA.110.608257. Epub 2011 Sep 22. Review.

39.

Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice.

Yang Y, Jalal FY, Thompson JF, Walker EJ, Candelario-Jalil E, Li L, Reichard RR, Ben C, Sang QX, Cunningham LA, Rosenberg GA.

J Neuroinflammation. 2011 Aug 29;8:108. doi: 10.1186/1742-2094-8-108.

40.

Blood-brain barrier permeability abnormalities in vascular cognitive impairment.

Taheri S, Gasparovic C, Huisa BN, Adair JC, Edmonds E, Prestopnik J, Grossetete M, Shah NJ, Wills J, Qualls C, Rosenberg GA.

Stroke. 2011 Aug;42(8):2158-63. doi: 10.1161/STROKEAHA.110.611731. Epub 2011 Jun 30.

41.

MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia.

Yang Y, Rosenberg GA.

Methods Mol Biol. 2011;762:333-45. doi: 10.1007/978-1-61779-185-7_24.

42.

Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment.

Candelario-Jalil E, Thompson J, Taheri S, Grossetete M, Adair JC, Edmonds E, Prestopnik J, Wills J, Rosenberg GA.

Stroke. 2011 May;42(5):1345-50. doi: 10.1161/STROKEAHA.110.600825. Epub 2011 Mar 31.

43.

Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping.

Taheri S, Gasparovic C, Shah NJ, Rosenberg GA.

Magn Reson Med. 2011 Apr;65(4):1036-42. doi: 10.1002/mrm.22686. Epub 2010 Dec 13. Erratum in: Magn Reson Med. 2011 May;65(5):1508.

44.

Multiple roles of metalloproteinases in neurological disorders.

Yang Y, Hill JW, Rosenberg GA.

Prog Mol Biol Transl Sci. 2011;99:241-63. doi: 10.1016/B978-0-12-385504-6.00006-3. Review.

PMID:
21238938
45.

Modeling of cerebellar hemorrhage.

Rosenberg GA.

Exp Neurol. 2011 Apr;228(2):157-9. doi: 10.1016/j.expneurol.2010.12.015. Epub 2010 Dec 28. Review. No abstract available.

46.

Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Rivera S, Khrestchatisky M, Kaczmarek L, Rosenberg GA, Jaworski DM.

J Neurosci. 2010 Nov 17;30(46):15337-57. doi: 10.1523/JNEUROSCI.3467-10.2010. Review.

47.

Vascular cognitive impairment: introduction.

Iadecola C, Hachinski V, Rosenberg GA.

Stroke. 2010 Oct;41(10 Suppl):S127-8. doi: 10.1161/STROKEAHA.110.595488. No abstract available.

48.

Critical role for copper/zinc-superoxide dismutase in preventing spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice.

Wakisaka Y, Chu Y, Miller JD, Rosenberg GA, Heistad DD.

Stroke. 2010 Apr;41(4):790-7. doi: 10.1161/STROKEAHA.109.569616. Epub 2010 Feb 11.

49.

Cyclooxygenase-1 and -2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activity.

Aid S, Silva AC, Candelario-Jalil E, Choi SH, Rosenberg GA, Bosetti F.

J Cereb Blood Flow Metab. 2010 Feb;30(2):370-80. doi: 10.1038/jcbfm.2009.223. Epub 2009 Oct 21.

50.

Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia.

Yang Y, Candelario-Jalil E, Thompson JF, Cuadrado E, Estrada EY, Rosell A, Montaner J, Rosenberg GA.

J Neurochem. 2010 Jan;112(1):134-49. doi: 10.1111/j.1471-4159.2009.06433.x. Epub 2009 Oct 15.

Supplemental Content

Loading ...
Support Center